A Phase II Study of the Docetaxel- Ifosfamide-Carboplatin Combination in Advanced Non-Small-Cell Lung Cancer

Purpose: In the present phase II study we evaluated the docetaxel-ifosfamide-carboplatin (DICb) combination in the outpatient setting in patients with advanced non-small-cell lung cancer (NSCLC). Patients and Methods: Patients with advanced NSCLC (stages IIIB/IV), WHO performance status (PS)

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Oncology 2005-01, Vol.69 (4), p.333-341
Hauptverfasser:	Kosmas, Christos, Tsavaris, Nicolas, Koutras, Aggelos, Makatsoris, Thomas, Mylonakis, Nicolas, Tzelepis, George, Dimitrakopoulos, Antonis, Spyropoulos, Konstantinos, Polyzos, Aristidis, Karabelis, Athanasios, Kalofonos, Haralambos P.
Format:	Artikel
Sprache:	eng
Schlagworte:	Actuarial Analysis Aged Antineoplastic Combined Chemotherapy Protocols - adverse effects Antineoplastic Combined Chemotherapy Protocols - therapeutic use Biological and medical sciences Carboplatin - administration & dosage Carcinoma, Non-Small-Cell Lung - drug therapy Carcinoma, Non-Small-Cell Lung - secondary Cells Clinical Study Clinical trials Drug Administration Schedule Drug therapy Female Humans Ifosfamide - administration & dosage Lung cancer Lung Neoplasms - drug therapy Lung Neoplasms - pathology Male Medical sciences Middle Aged Neoplasm Staging Pneumology Quality of Life Survival Analysis Taxoids - administration & dosage Treatment Outcome Tumors Tumors of the respiratory system and mediastinum
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!